TG
HZNP

TCW Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

TCW Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-62,721
Closed -$1.01M – 661
2016
Q4 		$1.01M Sell
62,721
-51,235
-45% -$929K 0.01% 492
2016
Q3 		$2.07M Sell
113,956
-4,440
-4% -$86.7K 0.02% 326
2016
Q2 		$1.95M Sell
118,396
-45,107
-28% -$730K 0.01% 330
2016
Q1 		$2.71M Buy
163,503
+5,203
+3% +$91K 0.02% 276
2015
Q4 		$3.43M Buy
158,300
+100,333
+173% +$1.95M 0.02% 247
2015
Q3 		$1.15M Buy
+57,967
New +$1.83M 0.01% 475

Other funds holding HZNP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return